Search results
Showing 16 to 30 of 158 results for atrial fibrillation
Atrial fibrillation: current treatment with anticoagulation (IND128)
This indicator covers the percentage of patients who are currently treated with anticoagulation drug therapy in those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM82
This indicator covers the percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring system in the preceding 12 months (excluding those patients with a previous CHADS2 or CHA2DS2-VASc score of 2 or more). It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM81
Atrial fibrillation: DOACs and Vitamin K antagonists (IND247)
This indicator covers the percentage of patients with atrial fibrillation and a last recorded CHA2DS2-VASc score of 2 or more who are currently prescribed a direct-acting oral anticoagulant (DOAC) if eligible, or a vitamin K antagonist if not eligible for a DOAC or a DOAC is declined, clinically unsuitable or not indicated. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM231
Safe and effective management of stroke prevention in atrial fibrillation
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia1 and its prevalence is increasing. A patient with...
attached to an electrophysiologist consultant reviews referred atrial fibrillation (AF) patients in clinic. There is a...
Screening secondary care patients for atrial fibrillation: The SOS-AF service
service is called Screening and Optimising Stroke Prevention in Atrial Fibrillation (SOS-AF). All people admitted to...
Chronic heart failure in adults: diagnosis and management (NG106)
This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.
Science Network (AHSN) Alliance for Atrial Fibrillation (AF) aims to reduce the number of people dying or disabled by...
The recent new NICE guidelines on Atrial Fibrillation suggest that the baseline prevalence for Atrial Fibrillation is...
Overprescribing of rivaroxaban in non-atrial fibrillation patients in primary care
prevention of stroke and systemic embolism in association with atrial fibrillation (AF) were excluded from the audit...
implantable cardiac monitor (ICM) diagnostic pathway for the detection of atrial fibrillation in cryptogenic stroke during the COVID-19...
TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation (MIB60)
NICE has developed a medtech innovation briefing (MIB) on the TactiCath Quartz catheter for percutaneous radiofrequency ablation in atrial fibrillation
NICE has developed a medtech innovation briefing (MIB) on the ThermoCool SmartTouch catheter for percutaneous radiofrequency ablation in atrial fibrillation
Percutaneous radiofrequency ablation for atrial fibrillation (IPG168)
Evidence-based recommendations on percutaneous radiofrequency ablation for atrial fibrillation. This involves inserting a catheter into the heart that produces heat to damage the nerves in the area with the abnormal elecritcal impulses.
View recommendations for IPG168Show all sections
Sections for IPG168
West Hampshire Clinical Commissioning Group (CCG) used the GRASP-AF audit tool (GRASP-AF is part of the GRASP suite of...